Govt Alert: General antibiotic treatment can be 'life -threatening' | Today news

New -delhi: The Indian Pharmacopoeia Commission (IPC), a body under the Ministry of Health, found a commonly used antibiotic combination – sulfamethoxazole and trimethoprim – to show serious adverse reactions. This fixed dose combination is a popular antimicrobial medication used to treat a wide variety of bacterial infections such as pneumonia, bronchitis, skin infection, granuloma, urinary tract infection, etc. “The analysis of adverse medicine reactions (ADRs) from the Pharmaceutical Supervision Program of India (PVPI) database has revealed that the suspected drug sulfamethoxazole + trimethoprim is used for indication (s) such as urinary tract infection; respiratory-strining infection, including bronchitis, lineing, brucellosis, Brucellosis, Brucellosis, Brucellosis, Brucellosis, Brucellosis, Brucellosis, Brucellosis, Broseless, Finer Fibrosis, Melioidosis, Listeriosis, Brucellosis, Finer Fibrosis, Listeriosis, Brucellos Granuloma Inguinale, Otitis Media, Pneumocystis Pneumonia – Show a adverse medicine reaction called leukopenia, ”IPC in a drug warning for the month of May, seen by coin. IPC has asked healthcare staff, patients and consumers to carefully monitor for any adverse reaction with the medicine and report to the authorities if such a reaction occurs. Medical experts have said that doctors should be careful when prescribing this combination, especially for vulnerable patients, and regular blood tests can help get any problems early. “Trimethoprim-sulfamethoxazole has been used for years to treat a series of common bacterial infections because it is effective and widely available. But the recent warning of the Indian FarmakopEEA commission about its link to leukopenie-a drop in white blood cell-is an important reminder that even known medicine can have serious side effects. Medicine, Paras Health Gurugram. The IPC monitor adverse reactions to medicine among the Indian population and recommends the Central Drugs Standard Control Organization (CDSCO) to make suitable regulatory decisions for the safe use of medicine. Earlier, Mint reported that the Medicine Control General of India State/UT’s ordered to oversee the sale of non -approved antibiotic combinations and to ensure that these cocktail medicine does not find their way to the market. The plan is to stop the wrong antibiotics. Last year, the IPC issued ten warnings for medicine safety. Antimicrobial resistance (AMR), often due to overuse or misunderstanding of drugs, has emerged as a serious and growing threat to public health around the world, with approximately 600,000 lives lost in India each year due to such AMR infections, according to the available data from the Chemical and Fertilizer Ministry. Inquiries sent to the spokesman of the Ministry of Health remained unanswered. According to Crisil Market Intelligence and Analytics, the market size of the anti-infective segment in India was around £ 251.3 billion for FY24. These include antibiotics, antiviral drugs and antifungal drugs.